Jpmorgan Chase & CO Mimedx Group, Inc. Transaction History

Jpmorgan Chase & CO

$1.14 Trillion
Q2 2024

A detailed history of Jpmorgan Chase & CO transactions in Mimedx Group, Inc. stock. As of the latest transaction made, Jpmorgan Chase & CO holds 81,372 shares of MDXG stock, worth $580,182. This represents 0.0% of its overall portfolio holdings.

Number of Shares

81,372

Previous 99,345 18.09%

Holding current value

$580,182

Previous $764,000 26.31%

% of portfolio

0.0%

Previous 0.0%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 12, 2024	SELL	$6.16 - $8.08 $110,713 - $145,221	-17,973 Reduced 18.09%	81,372 $563,000
Q1 2024 May 10, 2024	BUY	$7.61 - $8.63 $174,946 - $198,395	22,989 Added 30.11%	99,345 $764,000
Q4 2023 Feb 12, 2024	SELL	$5.7 - $9.14 $16,701 - $26,780	-2,930 Reduced 3.7%	76,356 $669,000
Q3 2023 Nov 14, 2023	SELL	$6.35 - $8.16 $71,691 - $92,126	-11,290 Reduced 12.46%	79,286 $577,000
Q2 2023 Aug 11, 2023	BUY	$3.14 - $6.61 $976 - $2,055	311 Added 0.34%	90,576 $598,000
Q1 2023 May 18, 2023	BUY	$2.97 - $4.81 $256,708 - $415,747	86,434 Added 2256.17%	90,265 $307,000
Q1 2023 May 11, 2023	SELL	$2.97 - $4.81 $193,949 - $314,107	-65,303 Reduced 94.46%	3,831 $13,000
Q4 2022 Feb 13, 2023	BUY	$2.63 - $3.45 $11,853 - $15,549	4,507 Added 6.97%	69,134 $192,000
Q3 2022 Nov 14, 2022	BUY	$2.71 - $4.22 $3,571 - $5,561	1,318 Added 2.08%	64,627 $186,000
Q2 2022 Aug 11, 2022	SELL	$3.17 - $5.0 $47,261 - $74,545	-14,909 Reduced 19.06%	63,309 $219,000
Q1 2022 May 11, 2022	BUY	$4.27 - $6.27 $47,858 - $70,274	11,208 Added 16.73%	78,218 $368,000
Q4 2021 Feb 10, 2022	SELL	$5.7 - $8.48 $107,735 - $160,280	-18,901 Reduced 22.0%	67,010 $405,000
Q3 2021 Nov 12, 2021	BUY	$5.52 - $15.83 $474,228 - $1.36 Million	85,911 New	85,911 $521,000

Others Institutions Holding MDXG

# of Institutions

222

Shares Held

96.2M

Call Options Held

115K

Put Options Held

189K

View Full List

About MIMEDX GROUP, INC.

Ticker MDXG
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 113,609,000
Market Cap $810M
Description
MiMedx Group, Inc. develops and distributes placental tissue allografts for various sectors of healthcare. It processes the human placental tissues utilizing its patented and proprietary PURION process to produce allografts that retains the tissue's inherent biological properties and regulatory proteins. The company's patented and proprietary pr...

More about MDXG

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Jpmorgan Chase & CO, based on Form 13F filings with the SEC.

News

Stay updated on Jpmorgan Chase & CO with notifications on news.

Account

Jpmorgan Chase & CO Mimedx Group, Inc. Transaction History